0      0

67364 - Session II: Gene Therapies and New Modalities Part I

‐ Sep 25, 2023 3:15pm

Session Speakers:

Development of an icIEF Assay for Monitoring AAV Capsid Proteins and Application to Gene Therapy Products 

Xiaoping He, Pfizer, Inc.

Quantitation of Coxsackievirus A21 Viral Proteins in Mixtures of Empty and Full Capsids using Capillary Western

Richard Rustandi, Merck & Co., Inc.

Using Peptide Nucleic Acid Hybridization Probes for Qualitative and Quantitative Analysis of Nucleic Acid Therapeutics by Capillary Electrophoresis

Andrei Hutanu, Ten23

Discussion: 15:00 - 15:15